Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes

Podocyte structural changes have been suggested to be involved in the pathogenesis of albuminuria in diabetes. We evaluated podocytes density, number, and structure in 67 white patients with type 2 diabetes: 21 normoalbuminuric (NA), 23 microalbuminuric (MA), and 23 proteinuric (P). Kidney function...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2003-04, Vol.52 (4), p.1031-1035
Hauptverfasser: DALLA VESTRA, Michele, MASIERO, Alessandra, ROITER, Anna Maria, SALLER, Alois, CREPALDI, Gaetano, FIORETTO, Paola
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1035
container_issue 4
container_start_page 1031
container_title Diabetes (New York, N.Y.)
container_volume 52
creator DALLA VESTRA, Michele
MASIERO, Alessandra
ROITER, Anna Maria
SALLER, Alois
CREPALDI, Gaetano
FIORETTO, Paola
description Podocyte structural changes have been suggested to be involved in the pathogenesis of albuminuria in diabetes. We evaluated podocytes density, number, and structure in 67 white patients with type 2 diabetes: 21 normoalbuminuric (NA), 23 microalbuminuric (MA), and 23 proteinuric (P). Kidney function and biopsy studies were performed; 20 kidney donors served as control subjects. Electron microscopic morphometric analysis was used to estimate numerical density of podocytes per glomerulus [Nv(epi/glom)], filtration slit length density per glomerulus (FSLv/glom), and foot process width (FPW). The number of podocytes per glomerulus (Epi N/glom) was obtained by multiplying Nv(epi/glom) by mean glomerular volume. Nv(epi/glom) was significantly decreased in all type 2 diabetic groups compared with control subjects and was lower in MA and P than in NA (P < 0.0001, ANOVA). Epi N/glom was lower in MA and P patients compared with control subjects (P < 0.002, ANOVA); however, there were no significant differences among the type 2 diabetic groups. In addition, MA and P had decreased FSLv/glom and increased FPW compared with NA (P < 0.005 for both, ANOVA). The albumin excretion rate was inversely related to Nv(epi/glom) and FSLv/glom and directly to FPW (P < 0.0005 for all), whereas there was no correlation with Epi N/glom. In conclusion, changes in podocyte structure and density occur since the early stages of diabetic nephropathy and might contribute to increasing albuminuria in type 2 diabetic patients. These findings also suggest that in white type 2 diabetic patients, the density of podocytes may be functionally more relevant than the absolute number.
doi_str_mv 10.2337/diabetes.52.4.1031
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_73156841</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A99746310</galeid><sourcerecordid>A99746310</sourcerecordid><originalsourceid>FETCH-LOGICAL-g409t-c95c5d93c4b0dccaa7a791c60595e21ddf9af62311a943423a86760269c645fb3</originalsourceid><addsrcrecordid>eNpt0V-LEzEQAPAgilerX8AHCYKHD7c1_zbZPMlR9Dwo3IMKvsiSZmfblG12L8nq7bc30h5SKfMwZPgxmUwQek3JgnGuPjTOrCFBXJRsIRaUcPoEzajmuuBM_XiKZoRQVlCl1QV6EeOOECJzPEcXlEnJhZIz9PM24qFvejslwM7vxjDhAB38Mj7lMz7c4Sz2MGxDP5i0nT7ir2lsHMS_IFcc-BTxb5e2OE0DYIYfJ3uJnrWmi_DqmOfo--dP35ZfitXdze3yelVsBNGpsLq0ZaO5FWvSWGuMMkpTK0mpS2C0aVptWsk4pUYLLhg3lVSSMKmtFGW75nN0eeg7hP5-hJjqvYsWus546MdYK05LWQma4dv_4K4fg8-z1YxKoSotqoyuDmhjOqidb_sUjN2Ah2C63kPrcvlaayUkz1ufo-IMz9HA3tlz_v2JzyTBQ9qYMca6ulmd0Ktz1PZdBxuo8w6Xdyf8zfF143oPTT0Etzdhqh-_O4N3R2CiNV0bjLcu_nNC6kpXlP8BoxC4Yw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216478948</pqid></control><display><type>article</type><title>Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>DALLA VESTRA, Michele ; MASIERO, Alessandra ; ROITER, Anna Maria ; SALLER, Alois ; CREPALDI, Gaetano ; FIORETTO, Paola</creator><creatorcontrib>DALLA VESTRA, Michele ; MASIERO, Alessandra ; ROITER, Anna Maria ; SALLER, Alois ; CREPALDI, Gaetano ; FIORETTO, Paola</creatorcontrib><description>Podocyte structural changes have been suggested to be involved in the pathogenesis of albuminuria in diabetes. We evaluated podocytes density, number, and structure in 67 white patients with type 2 diabetes: 21 normoalbuminuric (NA), 23 microalbuminuric (MA), and 23 proteinuric (P). Kidney function and biopsy studies were performed; 20 kidney donors served as control subjects. Electron microscopic morphometric analysis was used to estimate numerical density of podocytes per glomerulus [Nv(epi/glom)], filtration slit length density per glomerulus (FSLv/glom), and foot process width (FPW). The number of podocytes per glomerulus (Epi N/glom) was obtained by multiplying Nv(epi/glom) by mean glomerular volume. Nv(epi/glom) was significantly decreased in all type 2 diabetic groups compared with control subjects and was lower in MA and P than in NA (P &lt; 0.0001, ANOVA). Epi N/glom was lower in MA and P patients compared with control subjects (P &lt; 0.002, ANOVA); however, there were no significant differences among the type 2 diabetic groups. In addition, MA and P had decreased FSLv/glom and increased FPW compared with NA (P &lt; 0.005 for both, ANOVA). The albumin excretion rate was inversely related to Nv(epi/glom) and FSLv/glom and directly to FPW (P &lt; 0.0005 for all), whereas there was no correlation with Epi N/glom. In conclusion, changes in podocyte structure and density occur since the early stages of diabetic nephropathy and might contribute to increasing albuminuria in type 2 diabetic patients. These findings also suggest that in white type 2 diabetic patients, the density of podocytes may be functionally more relevant than the absolute number.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/diabetes.52.4.1031</identifier><identifier>PMID: 12663476</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Aged ; Albuminuria ; Basement Membrane - pathology ; Biological and medical sciences ; Blood Pressure ; Body Mass Index ; Complications and side effects ; Development and progression ; Diabetes ; Diabetes Mellitus, Type 2 - pathology ; Diabetes Mellitus, Type 2 - physiopathology ; Diabetic nephropathies ; Diabetic Nephropathies - pathology ; Diabetic Nephropathies - physiopathology ; Diabetic nephropathy ; Female ; Fundamental and applied biological sciences. Psychology ; Glomerular Filtration Rate ; Glycated Hemoglobin A - analysis ; Humans ; Kidney - physiopathology ; Kidney Glomerulus - pathology ; Kinetics ; Longitudinal studies ; Male ; Middle Aged ; Pathogenesis ; Permeability ; Type 2 diabetes</subject><ispartof>Diabetes (New York, N.Y.), 2003-04, Vol.52 (4), p.1031-1035</ispartof><rights>2003 INIST-CNRS</rights><rights>COPYRIGHT 2003 American Diabetes Association</rights><rights>Copyright American Diabetes Association Apr 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14698981$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12663476$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DALLA VESTRA, Michele</creatorcontrib><creatorcontrib>MASIERO, Alessandra</creatorcontrib><creatorcontrib>ROITER, Anna Maria</creatorcontrib><creatorcontrib>SALLER, Alois</creatorcontrib><creatorcontrib>CREPALDI, Gaetano</creatorcontrib><creatorcontrib>FIORETTO, Paola</creatorcontrib><title>Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>Podocyte structural changes have been suggested to be involved in the pathogenesis of albuminuria in diabetes. We evaluated podocytes density, number, and structure in 67 white patients with type 2 diabetes: 21 normoalbuminuric (NA), 23 microalbuminuric (MA), and 23 proteinuric (P). Kidney function and biopsy studies were performed; 20 kidney donors served as control subjects. Electron microscopic morphometric analysis was used to estimate numerical density of podocytes per glomerulus [Nv(epi/glom)], filtration slit length density per glomerulus (FSLv/glom), and foot process width (FPW). The number of podocytes per glomerulus (Epi N/glom) was obtained by multiplying Nv(epi/glom) by mean glomerular volume. Nv(epi/glom) was significantly decreased in all type 2 diabetic groups compared with control subjects and was lower in MA and P than in NA (P &lt; 0.0001, ANOVA). Epi N/glom was lower in MA and P patients compared with control subjects (P &lt; 0.002, ANOVA); however, there were no significant differences among the type 2 diabetic groups. In addition, MA and P had decreased FSLv/glom and increased FPW compared with NA (P &lt; 0.005 for both, ANOVA). The albumin excretion rate was inversely related to Nv(epi/glom) and FSLv/glom and directly to FPW (P &lt; 0.0005 for all), whereas there was no correlation with Epi N/glom. In conclusion, changes in podocyte structure and density occur since the early stages of diabetic nephropathy and might contribute to increasing albuminuria in type 2 diabetic patients. These findings also suggest that in white type 2 diabetic patients, the density of podocytes may be functionally more relevant than the absolute number.</description><subject>Aged</subject><subject>Albuminuria</subject><subject>Basement Membrane - pathology</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure</subject><subject>Body Mass Index</subject><subject>Complications and side effects</subject><subject>Development and progression</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - pathology</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Diabetic nephropathies</subject><subject>Diabetic Nephropathies - pathology</subject><subject>Diabetic Nephropathies - physiopathology</subject><subject>Diabetic nephropathy</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Glomerular Filtration Rate</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Humans</subject><subject>Kidney - physiopathology</subject><subject>Kidney Glomerulus - pathology</subject><subject>Kinetics</subject><subject>Longitudinal studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pathogenesis</subject><subject>Permeability</subject><subject>Type 2 diabetes</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0V-LEzEQAPAgilerX8AHCYKHD7c1_zbZPMlR9Dwo3IMKvsiSZmfblG12L8nq7bc30h5SKfMwZPgxmUwQek3JgnGuPjTOrCFBXJRsIRaUcPoEzajmuuBM_XiKZoRQVlCl1QV6EeOOECJzPEcXlEnJhZIz9PM24qFvejslwM7vxjDhAB38Mj7lMz7c4Sz2MGxDP5i0nT7ir2lsHMS_IFcc-BTxb5e2OE0DYIYfJ3uJnrWmi_DqmOfo--dP35ZfitXdze3yelVsBNGpsLq0ZaO5FWvSWGuMMkpTK0mpS2C0aVptWsk4pUYLLhg3lVSSMKmtFGW75nN0eeg7hP5-hJjqvYsWus546MdYK05LWQma4dv_4K4fg8-z1YxKoSotqoyuDmhjOqidb_sUjN2Ah2C63kPrcvlaayUkz1ufo-IMz9HA3tlz_v2JzyTBQ9qYMca6ulmd0Ktz1PZdBxuo8w6Xdyf8zfF143oPTT0Etzdhqh-_O4N3R2CiNV0bjLcu_nNC6kpXlP8BoxC4Yw</recordid><startdate>20030401</startdate><enddate>20030401</enddate><creator>DALLA VESTRA, Michele</creator><creator>MASIERO, Alessandra</creator><creator>ROITER, Anna Maria</creator><creator>SALLER, Alois</creator><creator>CREPALDI, Gaetano</creator><creator>FIORETTO, Paola</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>8GL</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20030401</creationdate><title>Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes</title><author>DALLA VESTRA, Michele ; MASIERO, Alessandra ; ROITER, Anna Maria ; SALLER, Alois ; CREPALDI, Gaetano ; FIORETTO, Paola</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g409t-c95c5d93c4b0dccaa7a791c60595e21ddf9af62311a943423a86760269c645fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Albuminuria</topic><topic>Basement Membrane - pathology</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure</topic><topic>Body Mass Index</topic><topic>Complications and side effects</topic><topic>Development and progression</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - pathology</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Diabetic nephropathies</topic><topic>Diabetic Nephropathies - pathology</topic><topic>Diabetic Nephropathies - physiopathology</topic><topic>Diabetic nephropathy</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Glomerular Filtration Rate</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Humans</topic><topic>Kidney - physiopathology</topic><topic>Kidney Glomerulus - pathology</topic><topic>Kinetics</topic><topic>Longitudinal studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pathogenesis</topic><topic>Permeability</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DALLA VESTRA, Michele</creatorcontrib><creatorcontrib>MASIERO, Alessandra</creatorcontrib><creatorcontrib>ROITER, Anna Maria</creatorcontrib><creatorcontrib>SALLER, Alois</creatorcontrib><creatorcontrib>CREPALDI, Gaetano</creatorcontrib><creatorcontrib>FIORETTO, Paola</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Gale In Context: High School</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DALLA VESTRA, Michele</au><au>MASIERO, Alessandra</au><au>ROITER, Anna Maria</au><au>SALLER, Alois</au><au>CREPALDI, Gaetano</au><au>FIORETTO, Paola</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2003-04-01</date><risdate>2003</risdate><volume>52</volume><issue>4</issue><spage>1031</spage><epage>1035</epage><pages>1031-1035</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>Podocyte structural changes have been suggested to be involved in the pathogenesis of albuminuria in diabetes. We evaluated podocytes density, number, and structure in 67 white patients with type 2 diabetes: 21 normoalbuminuric (NA), 23 microalbuminuric (MA), and 23 proteinuric (P). Kidney function and biopsy studies were performed; 20 kidney donors served as control subjects. Electron microscopic morphometric analysis was used to estimate numerical density of podocytes per glomerulus [Nv(epi/glom)], filtration slit length density per glomerulus (FSLv/glom), and foot process width (FPW). The number of podocytes per glomerulus (Epi N/glom) was obtained by multiplying Nv(epi/glom) by mean glomerular volume. Nv(epi/glom) was significantly decreased in all type 2 diabetic groups compared with control subjects and was lower in MA and P than in NA (P &lt; 0.0001, ANOVA). Epi N/glom was lower in MA and P patients compared with control subjects (P &lt; 0.002, ANOVA); however, there were no significant differences among the type 2 diabetic groups. In addition, MA and P had decreased FSLv/glom and increased FPW compared with NA (P &lt; 0.005 for both, ANOVA). The albumin excretion rate was inversely related to Nv(epi/glom) and FSLv/glom and directly to FPW (P &lt; 0.0005 for all), whereas there was no correlation with Epi N/glom. In conclusion, changes in podocyte structure and density occur since the early stages of diabetic nephropathy and might contribute to increasing albuminuria in type 2 diabetic patients. These findings also suggest that in white type 2 diabetic patients, the density of podocytes may be functionally more relevant than the absolute number.</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>12663476</pmid><doi>10.2337/diabetes.52.4.1031</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2003-04, Vol.52 (4), p.1031-1035
issn 0012-1797
1939-327X
language eng
recordid cdi_proquest_miscellaneous_73156841
source MEDLINE; EZB Electronic Journals Library
subjects Aged
Albuminuria
Basement Membrane - pathology
Biological and medical sciences
Blood Pressure
Body Mass Index
Complications and side effects
Development and progression
Diabetes
Diabetes Mellitus, Type 2 - pathology
Diabetes Mellitus, Type 2 - physiopathology
Diabetic nephropathies
Diabetic Nephropathies - pathology
Diabetic Nephropathies - physiopathology
Diabetic nephropathy
Female
Fundamental and applied biological sciences. Psychology
Glomerular Filtration Rate
Glycated Hemoglobin A - analysis
Humans
Kidney - physiopathology
Kidney Glomerulus - pathology
Kinetics
Longitudinal studies
Male
Middle Aged
Pathogenesis
Permeability
Type 2 diabetes
title Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A22%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20podocyte%20injury%20relevant%20in%20diabetic%20nephropathy?%20Studies%20in%20patients%20with%20type%202%20diabetes&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=DALLA%20VESTRA,%20Michele&rft.date=2003-04-01&rft.volume=52&rft.issue=4&rft.spage=1031&rft.epage=1035&rft.pages=1031-1035&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/diabetes.52.4.1031&rft_dat=%3Cgale_proqu%3EA99746310%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216478948&rft_id=info:pmid/12663476&rft_galeid=A99746310&rfr_iscdi=true